Abstract: A sensor arrangement for evaluating agricultural material, the arrangement comprising: a housing having an opening, the opening configured with a window transparent to electromagnetic waves; a detector arranged in the housing for detecting electromagnetic waves coming in through the window; a flexible seal element disposed between the window and the housing; and a compression member proximate at least one of the opening, the housing, the window and the seal element, the compression member configured to press the window against the seal element to seal off the housing.

Abstract: A sensor arrangement for evaluating agricultural material, the arrangement comprising: a housing having an opening, the opening configured with a window transparent to electromagnetic waves; a detector arranged in the housing for detecting electromagnetic waves coming in through the window; a flexible seal element disposed between the window and the housing; and a compression member proximate at least one of the opening, the housing, the window and the seal element, the compression member configured to press the window against the seal element to seal off the housing.

Abstract: The present invention provides for amorphous Letermovir and orally administrable solid pharmaceutical formulations thereof (immediate release formulation). Said amorphous Letermovir is suitable for immediate release formulations when isolated out of an organic solution by either roller-drying said organic solution in a volatile organic solvent, in particular acetone, at a temperature of 30° C. to 60° C., and subsequently drying the amorphous Letermovir obtained, or isolating said amorphous Letermovir by precipitation from water miscible solvents selected from acetone or acetonitrile into excess water as anti-solvent, and subsequently filtrating or centrifuging the amorphous Letermovir obtained. The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).

Abstract: A method is disclosed for controlling an internal combustion engine having a first adjustable camshaft for the actuating of first valve elements of the internal combustion engine. An effect of an actuation at least of a first valve element by the first camshaft on this valve element is detected. An actual position of the first camshaft and/or of a crankshaft driving the latter is detected on the basis of this detecting of the effect. An adjustment of the first camshaft is calibrated on the basis of a first deviation between this detected actual position and a predetermined required position.

Abstract: A method is disclosed for controlling an internal combustion engine having a first adjustable camshaft for the actuating of first valve elements of the internal combustion engine. An effect of an actuation at least of a first valve element by the first camshaft on this valve element is detected. An actual position of the first camshaft and/or of a crankshaft driving the latter is detected on the basis of this detecting of the effect. An adjustment of the first camshaft is calibrated on the basis of a first deviation between this detected actual position and a predetermined required position.

Abstract: The present invention provides for amorphous Letermovir and orally administrable solid pharmaceutical formulations thereof (immediate release formulation). Said amorphous Letermovir is suitable for immediate release formulations when isolated out of an organic solution by either roller-drying said organic solution in a volatile organic solvent, in particular acetone, at a temperature of 30° C. to 60° C., and subsequently drying the amorphous Letermovir obtained, or isolating said amorphous Letermovir by precipitation from water miscible solvents selected from acetone or acetonitrile into excess water as anti-solvent, and subsequently filtrating or centrifuging the amorphous Letermovir obtained. The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).

Abstract: Screw feeder (1) for transporting and/or metering pulverulent or granular material, having a rotatably mounted feeder screw (3) for the transport of material from a storage vessel (2) to a discharge opening (6), and having a variable-speed motor (4) for driving the feeder screw, characterized in that the speed is controlled by a programmable regulating device (7) which regulates the speed of the motor as a function of the respectively determined rotary position of the feeder screw within one full worm revolution.

Abstract: Screw feeder (1) for transporting and/or metering pulverulent or granular material, having a rotatably mounted feeder screw (3) for the transport of material from a storage vessel (2) to a discharge opening (6), and having a variable-speed motor (4) for driving the feeder screw, characterized in that the speed is controlled by a programmable regulating device (7) which regulates the speed of the motor as a function of the respectively determined rotary position of the feeder screw within one full worm revolution.